Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Morten Michael Voss
Observed names:
M Voss,
M. Voss,
Morten Voss
Institution:
University Medical Center of the Johannes Gutenberg University Mainz
Observed institutions:
Hôpital Beaujon,
University Medical Center Freiburg,
Christian-Albrechts-Universität zu Kiel,
University Medical Center of the Johannes Gutenberg University Mainz,
University of Bologna
ORCID:
0009-0002-3943-2575
Observed ORCID:
0009-0002-3943-2575
OpenAlex ID:
A5038575108
Value of endoscopic ultrasound guided fine needle aspiration biopsy in the diagnosis of solid pancreatic masses
2000
·
M Voss
, P Hammel
, et al.
·
Gut
·
390
PDF
Lack of telomerase activity in human mesenchymal stem cells
2003
·
S Zimmermann
, M Voss
, et al.
·
Leukemia
·
287
Prognostic factors in patients with endocrine tumours of the duodenopancreatic area
1998
·
I Madeira
, B Terris
, et al.
·
Gut
·
259
PDF
Human pancreatic adenocarcinomas express Fas and Fas ligand yet are resistant to Fas-mediated apoptosis.
1998
·
H Ungefroren
, M Voss
, et al.
·
PubMed
·
242
Autoantibodies in sera of pancreatic cancer patients identify recombination factor Rad51 as a tumour-associated antigen
2002
·
H. Maacke
, C. Hundertmark
, et al.
·
Journal of Cancer Research and Clinical Oncology
·
43
The effector program of human CD8 T cells supports tissue remodeling
2023
·
Michael Delacher
, Lisa Schmidleithner
, et al.
·
The Journal of Experimental Medicine
·
30
PDF
DNA hypomethylation traits define human regulatory T cells in cutaneous tissue and identify their blood recirculating counterparts
2025
·
Niklas Beumer
, Charles D. Imbusch
, et al.
·
Nature Immunology
·
9
[CD95 resistance and Fas ligand synthesis as mechanism of defense by immunocompetent cells in pancreatic tumors].
1998
·
H Ungefroren
, M Voss
, et al.
·
PubMed
·
2
Single-cell chromatin landscape and DNA methylation patterns reveal shared molecular programs in human tumor and non-tumor tissue CCR8 + Treg cells
2025
·
Kathrin Luise Braband
, Tamara Kaufmann
, et al.
·
bioRxiv (Cold Spring Harbor Laboratory)
·
1
TNFR2 agonism increases tissue and effector Treg cells
2026
·
Delia Mihaela Mihoc
, Elizabeth McMillan
, et al.
·
The Journal of Immunology
PDF
Molekulare Charakterisierung von »Tumor-Dormancy« beim Pankreaskarzinom Molecular characterization of tumor dormancy in pancreatic carcinoma
2004
·
M Voss
, H. Paulsen
, et al.
Diagnosis of pancreatic masses: The role of endoscopic ultrasound guided biopsy
1998
·
M Voss
, P Hammel
, et al.
·
Gastroenterology
CD95-Resistenz und Fas-Ligand-Synthese als Mechanismen der Abwehr immunkompetenter Zellen bei Pankreastumoren
1998
·
Hendrik Ungefroren
, M. Voss
, et al.
·
Springer eBooks
Molekularbiologie solider Tumoren: Eine Zusammenfassung wichtiger Forschungsergebnisse der letzten Jahre
1997
·
H. Kalthoff
, M. Voss
, et al.
·
Springer eBooks
Show more works
View as search
Works count:
14
Citation count:
1,263
H-index:
7
I10-index:
6
Year
Topic
Type